AAAAAA
Results:
1-12
|
Results: 12
Authors:
BLOHMER JU
TULUSAN AH
JACKISCH C
KAUFMANN M
COSTA SD
VONMINCKWITZ G
EIERMANN W
Citation: Ju. Blohmer et al., DOSE INTENSIFIED PREOPERATIVE CHEMOTHERAPY WITH DOXORUBICIN DOCETAXELIN OPERABLE BREAST-CANCER - A PHASE-II TRIAL/, Annals of oncology, 9, 1998, pp. 33-33
Authors:
BORQUEZ D
RAAB G
HARSTRICK A
WILKE HJ
ACHTERRATH W
EIERMANN W
SEEBER S
Citation: D. Borquez et al., PHASE-I STUDY OF DOCETAXEL (D) IN COMBINATION WITH EPIRUBICIN (E) AS FIRST LINE CHEMOTHERAPY IN METASTATIC BREAST-CANCER, Annals of oncology, 9, 1998, pp. 137-137
Authors:
RITZKE C
STIEBER P
UNTCH M
NAGEL D
EIERMANN W
FATEHMOGHADAM A
Citation: C. Ritzke et al., ALKALINE-PHOSPHATASE ISOENZYMES IN DETECTION AND FOLLOW-UP OF BREAST-CANCER METASTASES, Anticancer research, 18(2B), 1998, pp. 1243-1249
Authors:
BUZDAR AU
JONAT W
HOWELL A
JONES SE
BLOMQVIST CP
VOGEL CL
EIERMANN W
WOLTER JM
STEINBERG M
WEBSTER A
LEE D
Citation: Au. Buzdar et al., ANASTROZOLE VERSUS MEGESTROL-ACETATE IN THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CARCINOMA - RESULTS OF A SURVIVAL UPDATEBASED ON A COMBINED ANALYSIS OF DATA FROM 2 MATURE PHASE-III TRIALS, Cancer, 83(6), 1998, pp. 1142-1152
Authors:
JONAT W
HOWELL A
BLOMQVIST C
EIERMANN W
WINBLAD G
TYRRELL C
MAURIAC L
ROCHE H
LUNDGREN S
HELLMUND R
AZAB M
Citation: W. Jonat et al., A RANDOMIZED TRIAL COMPARING 2 DOSES OF THE NEW SELECTIVE AROMATASE INHIBITOR ANASTROZOLE (ARIMIDEX) WITH MEGESTROL-ACETATE IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER, European journal of cancer, 32A(3), 1996, pp. 404-412
Authors:
BUZDAR A
JONAT W
HOWELL A
JONES SE
BLOMQVIST C
VOGEL CL
EIERMANN W
WOLTER JM
AZAB M
WEBSTER A
PLOURDE PV
Citation: A. Buzdar et al., ANASTROZOLE, A POTENT AND SELECTIVE AROMATASE INHIBITOR, VERSUS MEGESTROL-ACETATE IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER - RESULTS OF OVERVIEW ANALYSIS OF 2 PHASE-III TRIALS, Journal of clinical oncology, 14(7), 1996, pp. 2000-2011
Authors:
CLASSEN SD
WOLF H
EIERMANN W
KOPP R
RIESKAMP G
SCHILDBERG FW
WILMANNS W
Citation: Sd. Classen et al., SOLUBLE CD44 STANDARD AND V6 IN SERUM OF BREAST-CANCER PATIENTS - AN INDICATOR FOR THERAPY RESPONSE, European journal of cancer, 31A, 1995, pp. 659-659
Authors:
JONAT W
KAUFMANN M
BLAMEY RW
HOWELL A
COLLINS JP
COATES A
EIERMANN W
JANICKE F
NJORDENSKOLD B
FORBES JF
KOLVENBAG GJCM
Citation: W. Jonat et al., A RANDOMIZED STUDY TO COMPARE THE EFFECT OF THE LUTEINIZING-HORMONE-RELEASING HORMONE (LHRH) ANALOG GOSERELIN WITH OR WITHOUT TAMOXIFEN IN PREMENOPAUSAL AND PERIMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER, European journal of cancer, 31A(2), 1995, pp. 137-142
Authors:
HARBECK N
UNTCH M
PACHE L
EIERMANN W
Citation: N. Harbeck et al., TUMOR-CELL DETECTION IN THE BONE-MARROW OF BREAST-CANCER PATIENTS AT PRIMARY THERAPY - RESULTS OF A 3-YEAR MEDIAN FOLLOW-UP, British Journal of Cancer, 69(3), 1994, pp. 566-571
Authors:
EIERMANN W
STOCKER S
BEYER W
BAUMGARTNER R
Citation: W. Eiermann et al., PHOTODYNAMIC LASER THERAPY IN GYNECOLOGIC AL ONCOLOGY, Archives of gynecology and obstetrics, 254(1-4), 1993, pp. 438-440
Authors:
BAUMGARTNER L
MEIER W
STIEBER P
FATEHMOGHADAM A
EIERMANN W
HEPP H
Citation: L. Baumgartner et al., VALUE OF TUMOR-MARKER CA-125 AS A PROGNOS TIC PARAMETER IN RECURRENT OVARIAN-CANCER, Archives of gynecology and obstetrics, 254(1-4), 1993, pp. 959-962
Authors:
ROMISCH M
BAUER F
DAPONTE A
MEIER W
DORIGO O
EIERMANN W
Citation: M. Romisch et al., LYMPHOCYTE SUBPOPULATIONS IN WOMEN WITH M ALIGNANT-TUMORS IN CORRELATION WITH KNOWN PROGNOSTIC FACTORS AND AS DISEASE PARAMETERS DURING CYTOKINE THERAPY, Archives of gynecology and obstetrics, 254(1-4), 1993, pp. 1091-1093
Risultati:
1-12
|